LRRK2 and Parkinson disease: Altogether, these data indicate that C/C cohesion deficits are a blood-based cellular biomarker which is detectable in lymphocytes from LRRK2 mutation carriers and some idiopathic PD patients as compared to healthy controls and which is responsive to LRRK2 kinase inhibition.